{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:14:23Z","timestamp":1790158463059,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Mental Health Res"],"DOI":"10.1038\/s44184-025-00129-7","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:44:35Z","timestamp":1747269875000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Subtyping first-episode psychosis based on longitudinal symptom trajectories using machine learning"],"prefix":"10.1038","volume":"4","author":[{"given":"Yanan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridha","family":"Joober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lepage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srividya","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Benrimoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"129_CR1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s001270050073","volume":"33","author":"L Magliano","year":"1998","unstructured":"Magliano, L. et al. Burden on the families of patients with schizophrenia: results of the BIOMED I study. Soc. Psychiatry Psychiatr. Epidemiol. 33, 405\u2013412 (1998).","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"129_CR2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s001270050192","volume":"35","author":"L Magliano","year":"2000","unstructured":"Magliano, L. et al. Family burden and coping strategies in schizophrenia: 1-year follow-up data from the BIOMED I study. Soc. Psychiatry Psychiatr. Epidemiol. 35, 109\u2013115 (2000).","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"129_CR3","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.biopsych.2005.04.034","volume":"58","author":"RC Kessler","year":"2005","unstructured":"Kessler, R. C. et al. The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R). Biol. Psychiatry 58, 668\u2013676 (2005).","journal-title":"Biol. Psychiatry"},{"key":"129_CR4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.euroneuro.2005.04.009","volume":"15","author":"W R\u00f6ssler","year":"2005","unstructured":"R\u00f6ssler, W., Salize, H. J., van Os, J. & Riecher-R\u00f6ssler, A. Size of burden of schizophrenia and psychotic disorders. Eur. Neuropsychopharmacol. 15, 399\u2013409 (2005).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"129_CR5","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1176\/appi.ajp.162.10.1785","volume":"162","author":"DO Perkins","year":"2005","unstructured":"Perkins, D. O., Gu, H., Boteva, K. & Lieberman, J. A. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am. J. Psychiatry 162, 1785\u20131804 (2005).","journal-title":"Am. J. Psychiatry"},{"key":"129_CR6","first-page":"CD013288","volume":"11","author":"S Puntis","year":"2020","unstructured":"Puntis, S. et al. Specialised early intervention teams for recent-onset psychosis. Cochrane Database Syst. Rev. 11, CD013288 (2020).","journal-title":"Cochrane Database Syst. Rev."},{"key":"129_CR7","doi-asserted-by":"crossref","unstructured":"Moller, P. A. D. Duration of untreated psychosis: are we ignoring the mode of initial development? Psychopathology 34, 8\u201314 (2001).","DOI":"10.1159\/000049274"},{"key":"129_CR8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1176\/ajp.145.5.578","volume":"145","author":"WT Carpenter Jr","year":"1988","unstructured":"Carpenter, W. T. Jr, Heinrichs, D. W. & Wagman, A. M. Deficit and nondeficit forms of schizophrenia: the concept. Am. J. Psychiatry 145, 578\u2013583 (1988).","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl 2","key":"129_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00004850-199605002-00002","volume":"11","author":"RW Buchanan","year":"1996","unstructured":"Buchanan, R. W. & Gold, J. M. Negative symptoms: diagnosis, treatment and prognosis. Int. Clin. Psychopharmacol. 11(Suppl 2), 3\u201311 (1996).","journal-title":"Int. Clin. Psychopharmacol."},{"key":"129_CR10","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1093\/schbul\/sbu170","volume":"41","author":"P Fusar-Poli","year":"2015","unstructured":"Fusar-Poli, P. et al. Treatments of negative symptoms in schizophrenia: meta-analysis of 168 randomized placebo-controlled trials. Schizophr. Bull. 41, 892\u2013899 (2015).","journal-title":"Schizophr. Bull."},{"key":"129_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/schbul\/sbj055","volume":"32","author":"SM Erhart","year":"2006","unstructured":"Erhart, S. M., Marder, S. R. & Carpenter, W. T. Treatment of schizophrenia negative symptoms: future prospects. Schizophr. Bull. 32, 234\u2013237 (2006).","journal-title":"Schizophr. Bull."},{"key":"129_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1017\/S003329171800048X","volume":"49","author":"D Lutgens","year":"2019","unstructured":"Lutgens, D. et al. Progress of negative symptoms over the initial 5 years of a first episode of psychosis. Psychol. Med. 49, 66\u201374 (2019).","journal-title":"Psychol. Med."},{"key":"129_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1192\/bjp.bp.116.197103","volume":"210","author":"D Lutgens","year":"2017","unstructured":"Lutgens, D., Gariepy, G. & Malla, A. Psychological and psychosocial interventions for negative symptoms in psychosis: systematic review and meta-analysis. Br. J. Psychiatry 210, 324\u2013332 (2017).","journal-title":"Br. J. Psychiatry"},{"key":"129_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-023-02661-6","volume":"13","author":"A Worker","year":"2023","unstructured":"Worker, A. et al. Extreme deviations from the normative model reveal cortical heterogeneity and associations with negative symptom severity in first-episode psychosis from the OPTiMiSE and GAP studies. Transl. Psychiatry 13, 373 (2023).","journal-title":"Transl. Psychiatry"},{"key":"129_CR15","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1176\/ajp.2006.163.4.743","volume":"163","author":"R Emsley","year":"2006","unstructured":"Emsley, R., Rabinowitz, J. & Medori, R. Time course for antipsychotic treatment response in first-episode schizophrenia. Am. J. Psychiatry 163, 743\u2013745 (2006).","journal-title":"Am. J. Psychiatry"},{"key":"129_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1001\/jamapsychiatry.2019.4910","volume":"77","author":"DB Dwyer","year":"2020","unstructured":"Dwyer, D. B. et al. An investigation of psychosis subgroups with prognostic validation and exploration of genetic underpinnings: the PsyCourse study. JAMA Psychiatry 77, 523\u2013533 (2020).","journal-title":"JAMA Psychiatry"},{"key":"129_CR17","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1038\/s41380-023-02069-0","volume":"28","author":"DB Dwyer","year":"2023","unstructured":"Dwyer, D. B. et al. Psychosis brain subtypes validated in first-episode cohorts and related to illness remission: results from the PHENOM consortium. Mol. Psychiatry 28, 2008\u20132017 (2023).","journal-title":"Mol. Psychiatry"},{"key":"129_CR18","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1017\/S0033291721004153","volume":"53","author":"PP Oomen","year":"2023","unstructured":"Oomen, P. P. et al. Longitudinal clinical and functional outcome in distinct cognitive subgroups of first-episode psychosis: a cluster analysis. Psychol. Med. 53, 2317\u20132327 (2023).","journal-title":"Psychol. Med."},{"key":"129_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/schbul\/sbab090","volume":"48","author":"BA Clementz","year":"2022","unstructured":"Clementz, B. A. et al. Psychosis biotypes: replication and validation from the B-SNIP Consortium. Schizophr. Bull. 48, 56\u201368 (2022).","journal-title":"Schizophr. Bull."},{"key":"129_CR20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/NMD.0000000000000288","volume":"203","author":"S Iyer","year":"2015","unstructured":"Iyer, S., Jordan, G., MacDonald, K., Joober, R. & Malla, A. Early intervention for psychosis: a Canadian perspective. J. Nerv. Ment. Dis. 203, 356\u2013364 (2015).","journal-title":"J. Nerv. Ment. Dis."},{"key":"129_CR21","unstructured":"Norman, R. M. G. & Malla, A. K. Course of Onset and Relapse Schedule: Interview and Coding Instruction Guide (Prevention and Early Intervention for Psychosis Program, 2002)."},{"key":"129_CR22","doi-asserted-by":"publisher","unstructured":"Andreasen, N. C. Scale for the assessment of positive symptoms. Psychiatr. Psychobiol. https:\/\/doi.org\/10.1037\/t48377-000.","DOI":"10.1037\/t48377-000"},{"key":"129_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1111\/acps.13011","volume":"139","author":"J-G Daneault","year":"2019","unstructured":"Daneault, J.-G. et al. Medication adherence in first episode psychosis: the role of pre-onset subthreshold symptoms. Acta Psychiatr. Scand. 139, 336\u2013347 (2019).","journal-title":"Acta Psychiatr. Scand."},{"key":"129_CR24","doi-asserted-by":"publisher","unstructured":"Schatzberg, A. & Debattista, C. Manual of Clinical Psychopharmacology. https:\/\/doi.org\/10.1176\/appi.books.9781615370047 (American Psychiatric Publishing, 1991).","DOI":"10.1176\/appi.books.9781615370047"},{"key":"129_CR25","doi-asserted-by":"publisher","first-page":"663","DOI":"10.4088\/JCP.v64n0607","volume":"64","author":"SW Woods","year":"2003","unstructured":"Woods, S. W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J. Clin. Psychiatry 64, 663\u2013667 (2003).","journal-title":"J. Clin. Psychiatry"},{"key":"129_CR26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.schres.2013.06.030","volume":"149","author":"MX Patel","year":"2013","unstructured":"Patel, M. X., Arista, I. A., Taylor, M. & Barnes, T. R. E. How to compare doses of different antipsychotics: a systematic review of methods. Schizophr. Res. 149, 141\u2013148 (2013).","journal-title":"Schizophr. Res."},{"key":"129_CR27","doi-asserted-by":"crossref","unstructured":"Taylor, D. M., Barnes, T. R. E. & Young, A. H. The Maudsley Prescribing Guidelines in Psychiatry (John Wiley & Sons, 2021).","DOI":"10.1002\/9781119870203"},{"key":"129_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.9740\/mhc.2017.09.201","volume":"7","author":"SR Saklad","year":"2017","unstructured":"Saklad, S. R. Graphic representation of pharmacology: development of an alternative model. Ment. Health Clin. 7, 201\u2013206 (2017).","journal-title":"Ment. Health Clin."},{"key":"129_CR29","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.2174\/1570159X15666170630163616","volume":"16","author":"S Siafis","year":"2018","unstructured":"Siafis, S., Tzachanis, D., Samara, M. & Papazisis, G. Antipsychotic drugs: from receptor-binding profiles to metabolic side effects. Curr. Neuropharmacol. 16, 1210\u20131223 (2018).","journal-title":"Curr. Neuropharmacol."},{"key":"129_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.schres.2017.07.033","volume":"193","author":"PH Rothe","year":"2018","unstructured":"Rothe, P. H., Heres, S. & Leucht, S. Dose equivalents for second generation long-acting injectable antipsychotics: the minimum effective dose method. Schizophr. Res. 193, 23\u201328 (2018).","journal-title":"Schizophr. Res."},{"key":"129_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/pcn.12242","volume":"69","author":"I Kusumi","year":"2015","unstructured":"Kusumi, I., Boku, S. & Takahashi, Y. Psychopharmacology of atypical antipsychotic drugs: from the receptor binding profile to neuroprotection and neurogenesis. Psychiatry Clin. Neurosci. 69, 243\u2013258 (2015).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"129_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-9-24","volume":"9","author":"RA Kroken","year":"2009","unstructured":"Kroken, R. A., Johnsen, E., Ruud, T., Wentzel-Larsen, T. & J\u00f8rgensen, H. A. Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study. BMC Psychiatry 9, 24 (2009).","journal-title":"BMC Psychiatry"},{"key":"129_CR33","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/schbul\/sbu001","volume":"40","author":"S Leucht","year":"2014","unstructured":"Leucht, S. et al. Dose equivalents for second-generation antipsychotics: the minimum effective dose method. Schizophr. Bull. 40, 314\u2013326 (2014).","journal-title":"Schizophr. Bull."},{"key":"129_CR34","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/schbul\/sbv037","volume":"41","author":"S Leucht","year":"2015","unstructured":"Leucht, S. et al. Dose equivalents for second-generation antipsychotic drugs: the classical mean dose method. Schizophr. Bull. 41, 1397\u20131402 (2015).","journal-title":"Schizophr. Bull."},{"key":"129_CR35","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","volume":"167","author":"DM Gardner","year":"2010","unstructured":"Gardner, D. M., Murphy, A. L., O\u2019Donnell, H., Centorrino, F. & Baldessarini, R. J. International consensus study of antipsychotic dosing. Am. J. Psychiatry 167, 686\u2013693 (2010).","journal-title":"Am. J. Psychiatry"},{"key":"129_CR36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","volume":"28","author":"DJ Stekhoven","year":"2011","unstructured":"Stekhoven, D. J. & B\u00fchlmann, P. MissForest\u2014non-parametric missing value imputation for mixed-type data. Bioinformatics 28, 112\u2013118 (2011).","journal-title":"Bioinformatics"},{"key":"129_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1109\/TIT.1982.1056489","volume":"28","author":"S Lloyd","year":"1982","unstructured":"Lloyd, S. Least squares quantization in PCM. IEEE Trans. Inf. Theory 28, 129\u2013137 (1982).","journal-title":"IEEE Trans. Inf. Theory"},{"key":"129_CR38","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825\u20132830 (2011).","journal-title":"J. Mach. Learn. Res."},{"key":"129_CR39","doi-asserted-by":"publisher","unstructured":"Shahapure, K. R. & Nicholas, C. Cluster Quality Analysis Using Silhouette Score. In: Proc. IEEE 7th International Conference on Data Science and Advanced Analytics (DSAA) 747\u2013748. https:\/\/doi.org\/10.1109\/DSAA49011.2020.00096 (IEEE, 2020).","DOI":"10.1109\/DSAA49011.2020.00096"},{"key":"129_CR40","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.2517-6161.1958.tb00292.x","volume":"20","author":"DR Cox","year":"1958","unstructured":"Cox, D. R. The regression analysis of binary sequences. J. R. Stat. Soc. Ser. B Stat. Methodol. 20, 215\u2013232 (1958).","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol."},{"key":"129_CR41","doi-asserted-by":"publisher","unstructured":"Ng, A. Y. Feature selection, L1 vs. L2 regularization, and rotational invariance. In Proceedings of the Twenty-First International Conference on Machine learning. 78. https:\/\/doi.org\/10.1145\/1015330.1015435 (Association for Computing Machinery, 2004).","DOI":"10.1145\/1015330.1015435"},{"key":"129_CR42","unstructured":"Lundberg, S. M. & Lee, S.-I. A Unified Approach to Interpreting Model Predictions. in Advances in Neural Information Processing Systems 30 (eds. Guyon, I. et al.) 4765\u20134774 (Curran Associates, Inc., 2017)."},{"key":"129_CR43","unstructured":"Association, A. P. & Others. Diagnostic and statistical manual of mental disorders. Text Revision (2000)."},{"key":"129_CR44","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall, J. E. & Gorham, D. R. The brief psychiatric rating scale. Psychol. Rep. 10, 799\u2013812 (1962).","journal-title":"Psychol. Rep."},{"key":"129_CR45","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.schres.2015.07.021","volume":"168","author":"SF Austin","year":"2015","unstructured":"Austin, S. F. et al. Long-term trajectories of positive and negative symptoms in first episode psychosis: a 10 year follow-up study in the OPUS cohort. Schizophr. Res. 168, 84\u201391 (2015).","journal-title":"Schizophr. Res."},{"key":"129_CR46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.schres.2021.08.021","volume":"237","author":"S Amoretti","year":"2021","unstructured":"Amoretti, S. et al. Cognitive clusters in first-episode psychosis. Schizophr. Res. 237, 31\u201339 (2021).","journal-title":"Schizophr. Res."},{"key":"129_CR47","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/eip.12412","volume":"11","author":"J Immonen","year":"2017","unstructured":"Immonen, J., J\u00e4\u00e4skel\u00e4inen, E., Korpela, H. & Miettunen, J. Age at onset and the outcomes of schizophrenia: a systematic review and meta-analysis.Early Interv. sychiatry 11, 453\u2013460 (2017).","journal-title":"Early Interv. sychiatry"},{"key":"129_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck, C. H. et al. Lecanemab in Early Alzheimer\u2019s disease. N. Engl. J. Med. 388, 9\u201321 (2023).","journal-title":"N. Engl. J. Med."},{"key":"129_CR49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.schres.2016.09.017","volume":"178","author":"E Roche","year":"2016","unstructured":"Roche, E. et al. The prognostic value of formal thought disorder following first episode psychosis. Schizophr. Res. 178, 29\u201334 (2016).","journal-title":"Schizophr. Res."},{"key":"129_CR50","doi-asserted-by":"crossref","unstructured":"Mourgues-Codern, C. et al. Emergence and dynamics of delusions and hallucinations across stages in early psychosis. arXiv [q-bio.NC] (2024).","DOI":"10.1016\/j.biopsych.2025.02.891"},{"key":"129_CR51","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/08039488.2020.1745273","volume":"74","author":"J Bjarke","year":"2020","unstructured":"Bjarke, J. et al. Different response patterns in hallucinations and delusions to antipsychotic treatment. Nord. J. Psychiatry 74, 497\u2013504 (2020).","journal-title":"Nord. J. Psychiatry"},{"key":"129_CR52","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1176\/appi.ajp.2015.14091200","volume":"173","author":"BA Clementz","year":"2016","unstructured":"Clementz, B. A. et al. Identification of distinct psychosis biotypes using brain-based biomarkers. Am. J. Psychiatry 173, 373\u2013384 (2016).","journal-title":"Am. J. Psychiatry"},{"key":"129_CR53","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/schbul\/sby008","volume":"44","author":"DB Dwyer","year":"2018","unstructured":"Dwyer, D. B. et al. Brain subtyping enhances the neuroanatomical discrimination of schizophrenia. Schizophr. Bull. 44, 1060\u20131069 (2018).","journal-title":"Schizophr. Bull."},{"key":"129_CR54","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.schres.2023.12.013","volume":"264","author":"Y Ji","year":"2024","unstructured":"Ji, Y. et al. Identifying psychosis subtypes use individualized covariance structural differential networks and multi-site clustering. Schizophr. Res. 264, 130\u2013139 (2024).","journal-title":"Schizophr. Res."},{"key":"129_CR55","doi-asserted-by":"publisher","first-page":"109907","DOI":"10.1016\/j.pnpbp.2020.109907","volume":"100","author":"\u00c1 Planchuelo-G\u00f3mez","year":"2020","unstructured":"Planchuelo-G\u00f3mez, \u00c1 et al. Identificacion of MRI-based psychosis subtypes: replication and refinement. Prog. Neuropsychopharmacol. Biol. Psychiatry 100, 109907 (2020).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"129_CR56","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/schbul\/sbab110","volume":"48","author":"Y Xiao","year":"2022","unstructured":"Xiao, Y. et al. Subtyping schizophrenia patients based on patterns of structural brain alterations. Schizophr. Bull. 48, 241\u2013250 (2022).","journal-title":"Schizophr. Bull."},{"key":"129_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.schres.2017.12.008","volume":"214","author":"N Honnorat","year":"2019","unstructured":"Honnorat, N., Dong, A., Meisenzahl-Lechner, E., Koutsouleris, N. & Davatzikos, C. Neuroanatomical heterogeneity of schizophrenia revealed by semi-supervised machine learning methods. Schizophr. Res. 214, 43\u201350 (2019).","journal-title":"Schizophr. Res."},{"key":"129_CR58","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/schbul\/sbz112","volume":"46","author":"Y Pan","year":"2020","unstructured":"Pan, Y. et al. Morphological profiling of schizophrenia: cluster analysis of MRI-based cortical thickness data. Schizophr. Bull. 46, 623\u2013632 (2020).","journal-title":"Schizophr. Bull."},{"key":"129_CR59","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1038\/s41380-023-02114-y","volume":"28","author":"D Benrimoh","year":"2023","unstructured":"Benrimoh, D. et al. Barriers and solutions to the adoption of translational tools for computational psychiatry. Mol. Psychiatry 28, 2189\u20132196 (2023).","journal-title":"Mol. Psychiatry"},{"key":"129_CR60","unstructured":"Hollingshead, A. B. Four factor index of social status (1975)."},{"key":"129_CR61","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0920-9964(90)90005-R","volume":"3","author":"D Addington","year":"1990","unstructured":"Addington, D., Addington, J. & Schissel, B. A depression rating scale for schizophrenics. Schizophr. Res. 3, 247\u2013251 (1990).","journal-title":"Schizophr. Res."}],"container-title":["npj Mental Health Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44184-025-00129-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44184-025-00129-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44184-025-00129-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T02:02:46Z","timestamp":1747274566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44184-025-00129-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["129"],"URL":"https:\/\/doi.org\/10.1038\/s44184-025-00129-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.09.17.24313827","asserted-by":"object"}]},"ISSN":["2731-4251"],"issn-type":[{"value":"2731-4251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.B. is a founder and shareholder of Aifred Health, a digital mental health company which was not involved in this work. M.L. reports grants from Roche Canada, grants from Otsuka Lundbeck Alliance, grants and personal fees from Janssen, and personal fees from Otsuka Canada, Lundbeck Canada, and Boehringer Ingelheim outside the submitted work. All other authors declare that there are no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}